| NEUROBIOLOGY OF AGING | 卷:33 |
| Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis | |
| Article | |
| Abramzon, Yevgeniya1  Johnson, Janel O.1  Scholz, Sonja W.2,3  Taylor, J. P.4  Brunetti, Maura5  Calvo, Andrea6  Mandrioli, Jessica7,8  Benatar, Michael9  Mora, Gabriele10  Restagno, Gabriella5  Chio, Adriano6  Traynor, Bryan J.1,11  | |
| [1] NIA, Neuromuscular Dis Res Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA | |
| [2] NIA, Mol Genet Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA | |
| [3] Georgetown Univ, Dept Neurosci, Washington, DC USA | |
| [4] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA | |
| [5] ASO OIRM S, Dept Clin Pathol, Mol Genet Unit, Turin, Italy | |
| [6] Univ Turin, Dept Neurosci, Turin, Italy | |
| [7] S Agostino Estense Hosp, Dept Neurosci, Modena, Italy | |
| [8] Univ Modena, I-41100 Modena, Italy | |
| [9] Univ Miami, Dept Neurol, Miami, FL USA | |
| [10] ALS Ctr, Salvatore Maugeri Fdn, Milan, Italy | |
| [11] Johns Hopkins Univ, Dept Neurol, Brain Sci Inst, Baltimore, MD 21218 USA | |
| 关键词: Amyotrophic lateral sclerosis; Valosin-containing protein; Mutations; Sporadic disease; | |
| DOI : 10.1016/j.neurobiolaging.2012.04.005 | |
| 来源: Elsevier | |
PDF
|
|
【 摘 要 】
We recently reported that mutations in the valosin-containing protein (VCP) gene are a cause of 1%-2% of familial amyotrophic lateral sclerosis (ALS) cases, but their role in the pathogenesis of sporadic ALS is unclear. We undertook mutational screening of VCP in 701 sporadic ALS cases. Three pathogenic variants (p.Arg159Cys, p.Asn387Thr, and p.R662C) were found in three U. S. cases, each of whom presented with progressive upper and lower motor neuron signs consistent with definite ALS by El Escorial diagnostic criteria. Our data indicate that VCP mutations may underlie apparently sporadic ALS but account for <1% of this form of disease. (C) 2012 Elsevier Inc. All rights reserved.
【 授权许可】
Free
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 10_1016_j_neurobiolaging_2012_04_005.pdf | 1774KB |
PDF